OMass Therapeutics is focused on identifying new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry, and custom chemistry
OMass Therapeutics is focused on identifying new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry, and custom chemistry. The company is advancing a pipeline of small molecule therapeutics aimed at orphan diseases and immunological conditions.